Aktuellt
SENASTE
Redeye leaves its initial take on Physitrack’s Q2 figures, which overall was line with our expectations. Highlights include an annual recurring revenue (ARR) increase of 13% y/y and Software as a Service (SaaS) revenues now constituting 82% (71%) of total revenues. We anticipate moderate adjustments to our near-term estimates and fair value range.
LÄS MER
